Omar Saad Alkahtani

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Molecular Docking

Small Cell Lung Cancer

Protein Protein

Top Venues

Medical oncology (Northwood, London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Abdulkarim S Binshaya, Omar Saad Alkahtani, Fahad M Aldakheel, Ahmed Hjazi, Hassan Hussain Almasoudi
Structure-based multitargeted docking screening, pharmacokinetics, DFT, and dynamics simulation studies reveal mitoglitazone as a potent inhibitor of cellular survival and stress response proteins of lung cancer. Medical oncology (Northwood, London, England) 41 (5) (2024)
Abdulkarim S Binshaya, Omar Saad Alkahtani, Fahad M Aldakheel, Ahmed Hjazi, Hassan Hussain Almasoudi
Structure-based multitargeted docking screening, pharmacokinetics, DFT, and dynamics simulation studies reveal mitoglitazone as a potent inhibitor of cellular survival and stress response proteins of lung cancer. Medical oncology (Northwood, London, England) 41 (5) (2024)
Abdulkarim S Binshaya, Omar Saad Alkahtani, Fahad M Aldakheel, Ahmed Hjazi, Hassan Hussain Almasoudi
Structure-based multitargeted docking screening, pharmacokinetics, DFT, and dynamics simulation studies reveal mitoglitazone as a potent inhibitor of cellular survival and stress response proteins of lung cancer. Medical oncology (Northwood, London, England) 41 (5) (2024)